Pharmacopé
0834.892.064 · rovalta.com · 09/11/2026
Pharmacopé
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPharmacopé is a Private limited company incorporated in 2011. Its main activity is: Activities of head offices. Its registered office is in Turnhout.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0834.892.064
- Incorporation
- 24/03/2011
- Legal form
- Private limited company
- Registered office
- Oude Vaartstraat 9
2300 Turnhout · FlandreSee on map - Contributed capital
- 18 550,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -761,3 € | -105% | 15,7 k € | -82.2% | 88,1 k € | +144% | 36,1 k € | -61.3% | 93,3 k € |
| EBITDA | -2,1 k € | -115% | 14,2 k € | -83.6% | 86,4 k € | +147% | 34,9 k € | -62.1% | 92,1 k € |
| Operating result | -2,3 k € | -117% | 13,7 k € | -81.6% | 74,8 k € | +217% | 23,6 k € | -70.8% | 80,6 k € |
| Net result | -931,2 € | -109% | 10,8 k € | -79.5% | 52,6 k € | +222% | 16,3 k € | -72.1% | 58,6 k € |
| Balance sheet | |||||||||
| Equity | 202 k € | -0.5% | 202,9 k € | +5.6% | 192,1 k € | +36.9% | 140,4 k € | +13.2% | 124 k € |
| Total assets | 208,1 k € | +0.6% | 206,9 k € | -0.6% | 208 k € | +35.7% | 153,3 k € | +3.0% | 148,9 k € |
| Cash | 51,5 k € | -30.8% | 74,4 k € | -29.0% | 104,8 k € | -16.8% | 126 k € | +17.1% | 107,6 k € |
| Debts | 6,2 k € | +56.2% | 3,9 k € | -75.2% | 15,9 k € | +23.3% | 12,9 k € | -48.0% | 24,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jan Peeters | DirectorManager2018 accountsended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2026 | 10/06/2025 | 28/06/2024 | 14/07/2023 | 20/06/2022 | 17/06/2021 |
| General meeting | 01/06/2026 | 02/06/2025 | 03/06/2024 | 05/06/2023 | 07/06/2022 | 07/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 01/06/2026 | 23/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 02/06/2025 | 10/06/2025 | Dutch | |
| Abridged model | 31/12/2023 | 03/06/2024 | 28/06/2024 | Dutch | |
| Abridged model | 31/12/2022 | 05/06/2023 | 14/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 07/06/2022 | 20/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 07/06/2021 | 17/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 02/06/2020 | 02/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 03/06/2019 | 06/06/2019 | Dutch | |
| Abridged model | 31/12/2017 | 04/06/2018 | 28/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 06/06/2017 | 09/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 06/06/2016 | 08/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 01/06/2015 | 05/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 02/06/2014 | 06/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 03/06/2013 | 07/06/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Jan Peeters | DirectorManager2018 accountsended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Oude Vaartstraat 9, 2300 TurnhoutCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00207102 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| PharmacopéCurrent | accounts 2012 → 2025 | Accounts 2025 · 2026-00207102 |
Events
- 2025Annual accounts 2025-931,2 €↓
- 2024Annual accounts 202410,8 k €↓
- 2023Annual accounts 202352,6 k €↑
- 2022Annual accounts 202216,3 k €↓
- 2021Annual accounts 202158,6 k €↑
- 2020Annual accounts 202038,8 k €↑
- 2019Annual accounts 201924,1 k €↑
- 2018Annual accounts 201810,5 k €↑
- 2017Annual accounts 20171,5 k €↓
- 2016Annual accounts 20162,1 k €↓
- 2015Annual accounts 20157,9 k €↑
- 2014Annual accounts 2014388 €↓
- 2013Annual accounts 201314 k €↑
- 2012Annual accounts 2012-3,4 k €
- 24/03/2011IncorporationPrivate limited company